Efficacy and safety of the anti–PD-L1 monoclonal antibody socazolimab for recurrent or metastatic cervical cancer: Results from the phase I dose-escalation and expansion study. This is an ASCO Meeting ...
Cost utility analysis of a randomized radiation therapy trial among patients with one to three brain metastases. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract ...
The IAEA’s training has not only expanded treatment options for children in East Africa, but also raised the standard of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback